Compounded Medication Expiration Dates: Are They Still Good After the Label?

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Compounded medications have Beyond-Use Dates (BUDs) that are typically shorter than commercial drug expiration dates, reflecting the stability of custom preparations and the absence of extensive long-term stability testing.

# Compounded Medication Expiration Dates: Your FAQ Guide to Beyond-Use Dates (BUD)

If you\'re using compounded medications, you\'ve likely noticed that their "expiration dates" – more accurately termed Beyond-Use Dates (BUDs) – are often much shorter than those on commercial drugs. This can lead to confusion and concern: is the medication still effective? Is it safe to use past that date? Understanding the science and regulations behind BUDs is crucial for ensuring the safety and efficacy of your customized therapy. This guide will clarify why compounded medications have different dating and what it means for you.

What is a Beyond-Use Date (BUD)?

A Beyond-Use Date (BUD) is the date after which a compounded preparation should not be used. It is established by the compounding pharmacist based on the stability of the ingredients, the dosage form, storage conditions, and scientific literature. Unlike an expiration date, which is determined by a manufacturer after extensive product-specific stability testing for commercially produced drugs, a BUD is assigned to a compounded preparation [1].

BUD vs. Expiration Date: A Critical Distinction

| Feature | Beyond-Use Date (BUD) for Compounded Medications | Expiration Date for Commercial Medications |

| :----------------------- | :------------------------------------------------------- | :------------------------------------------------------- |

| Determined By | Compounding Pharmacist | Drug Manufacturer (with FDA approval) |

| Based On | Ingredient stability, dosage form, storage, USP guidelines | Extensive product-specific stability testing |

| Purpose | Ensures potency, purity, and sterility of compounded prep | Guarantees full potency and safety of manufactured drug |

| Typical Duration | Shorter (days to months) | Longer (1-5 years) |

| Regulatory Basis | USP General Chapters <795> and <797> | FDA Drug Approval Process (cGMP) |

Factors Influencing a Compounded Medication\'s BUD

The BUD for a compounded medication is not arbitrary; it\'s carefully determined by the pharmacist based on several factors:

  • Ingredient Stability: The inherent stability of the active pharmaceutical ingredients (APIs) and excipients (inactive ingredients) used. Some compounds degrade faster than others.
  • Dosage Form: Liquids, creams, and sterile injectables often have shorter BUDs than solid dosage forms like capsules, due to increased susceptibility to microbial growth or chemical degradation.
  • Storage Conditions: Whether the medication is stored at room temperature, refrigerated, or frozen significantly impacts its stability.
  • Packaging: The type of container (e.g., amber glass, plastic, air-tight) can affect how well the medication is protected from light, air, and moisture.
  • Sterility Considerations: For sterile preparations (like injectables), the risk of microbial contamination after compounding is a major factor in assigning a BUD, often leading to very short dates (e.g., 28 days for multi-dose vials) [2].

    • Why Compounded Medications Often Have Shorter BUDs

    The primary reason for shorter BUDs on compounded medications is the absence of extensive, long-term stability studies that commercial drugs undergo. Pharmaceutical manufacturers invest millions in testing their products under various conditions for years to establish a precise expiration date. Compounding pharmacies, by their nature, create individualized preparations, making such extensive testing for every unique compound impractical and cost-prohibitive. Instead, pharmacists rely on established guidelines from the United States Pharmacopeia (USP) General Chapters <795> (for non-sterile) and <797> (for sterile compounding) to assign conservative BUDs [3]. These guidelines provide default BUDs based on the type of preparation and its water content, ensuring a margin of safety.

    Practical Takeaway

    The Beyond-Use Date (BUD) on your compounded medication is a critical safety and efficacy indicator, determined by your compounding pharmacist based on scientific principles and regulatory guidelines. It is not an arbitrary date. Do not use compounded medications past their BUD. Doing so risks reduced potency, altered chemical composition, or even microbial contamination, which can render the medication ineffective or harmful. Always store your compounded medications as directed and dispose of them properly once the BUD is reached. If you have questions about your medication\'s BUD or stability, always consult directly with your compounding pharmacist. They are the experts in ensuring your customized therapy remains safe and effective throughout its intended use period.

    References

    [1] FDA. (2025). Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

    [2] Professional Compounding Centers of America (PCCA). (Unknown). Beyond-Use Dates for Compounded Preparations. https://www.pccarx.com/what-is-compounding/beyond-use-dates

    [3] The Compounding Lab. (2025). What is the Difference Between Compounded and Commercial Medications?. https://www.thecompoundinglab.com/compounding-pharmacy-news/what-is-the-difference-between-compounded-and-commercial-medications

    [4] International Journal of Pharmaceutical Compounding. (Unknown). Beyond-Use Dates: A Critical Review. https://www.ijpc.com/abstracts/abstract.cfm?ID=912